join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
Learn latest news of our company
follow developments of our company
News & Trends
30
2025-09
Breaking News: Salubris Achieves Phase Progress in...
29
2025-09
Latest! Salubris' SAL0140 New Indication Clin...
19
2025-09
Salubris' Class 1 Biological Drug Ticalicibar...
05
2025-09
Great News! Enaroy® Gains New Indication Approval ...
05
2025-09
Salubris' Small Molecule Drug SAL0139 Clinica...
Learn more News & Trends